The Centers for Medicare & Medicaid Services Feb. 25 released a request for information on potential regulatory changes in a ...
CMS has finalized several changes for the third round of Medicare drug price negotiations. The changes, outlined in a final guidance issued Sept. 30, include expanded exclusions for orphan drugs and a ...
The Biden administration has released new guidance for its program that will allow Medicare to directly negotiate the prices of certain drugs with manufacturers. The updated guidelines clarify how the ...
The Centers for Medicare & Medicaid Services (CMS) has pulled Biden-era guidance telling hospital emergency departments to provide abortion services as stabilizing care regardless of state law. The ...
Federal regulators have delayed survey enforcement of updated nursing home operational guidance an additional month. The Centers for Medicare & Medicaid Service announced the delay in a revised memo ...
The Centers for Medicare and Medicaid Services has released revised guidance on how it intends to use its authority with pharmaceutical manufacturers in the Medicare Drug Negotiation Program. For drug ...
The Centers for Medicare and Medicaid Services this week released the final part two guidance regarding plan outreach and education for the Medicare Prescription Payment Plan, which aims to ensure ...
David Wright, CMS director of quality, safety and oversight. (Photo: CMS) The Centers for Medicare & Medicaid Services on Monday issued “significant revisions” to its long-term care surveyor guidance, ...
In late November, CMS revised guidance for surveyors and healthcare providers regarding immediate jeopardy — the most serious type of warning for noncompliance deficiencies that place organizations at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results